Key result
Lifestyle preference drives ~52% of statin refusals among high-risk patients.
Why the study?
What are the reasons for non-acceptance of statin therapy in patients at high cardiovascular risk?
Observational
What are the reasons for non-acceptance of statin therapy in patients at high cardiovascular risk?
Answers are grounded in this paper and cite their sources.
Patient reluctance to initiate statin therapy is primarily driven by preference for lifestyle modifications, aversion to medications, polypharmacy burden, and fear of adverse reactions, which are often linked to past medical experiences.
Statins are a cornerstone of cardiovascular risk reduction. Nevertheless, non-acceptance of statin therapy recommendations by patients at high cardiovascular risk is common. The reasons for statin non-acceptance have not been well established. We conducted a manual record review of a randomly selected set of patients who did not accept statin therapy recommendations to identify (a) documented reasons for statin non-acceptance and (b) patients' demographic characteristics, comorbidities and current treatment. We analyzed the relationships between patients' characteristics and reasons for statin non-acceptance. The most common reasons for statin non-acceptance were preference for lifestyle modifications (51.5%), general aversion to medications (19.1%), polypharmacy burden (17.1%) and fear of adverse reactions (10.9%). Patients taking more medications were more likely to express a concern about polypharmacy burden (OR 1.09; 95% CI 1.005-1.18). Patients who previously had adverse reactions to non-cholesterol lowering medications were more likely to fear adverse reactions to statins (OR 1.13; 95% CI 1.001-1.28). Patients who expressed preference for lifestyle modifications had time to low density lipoprotein cholesterol (LDL-C) < 100 mg/dL similar to patients who did not accept statin therapy for other reasons (1935 vs. 1777 days, p = 0.26). Patients' reasons for non-acceptance of statin therapy are often linked to their past and present medical experience. Appropriately addressing these concerns is important to maximizing cardiovascular risk reduction in individuals who may be reluctant to initiate statin therapy.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2025) conducted an observational in High cardiovascular risk. Statin non-acceptance was evaluated on Documented reasons for statin non-acceptance. Among patients at high cardiovascular risk, the most common reasons for statin non-acceptance were preference for lifestyle modifications and general aversion to medications.
Synapse has enriched 10 related papers. Consider them for comparative context: